Applied Health Economics and Health Policy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The Inflation Reduction Act: Hope for Prescription Drug Prices in the USA
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - October 6, 2023 Category: Health Management Source Type: research

A Systematic Review of the World ’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana
ConclusionsConcerted efforts such as population-wide  dissemination of clear and complete knowledge of the scheme, providing training to healthcare providers, addressing infrastructural gaps and concerns of healthcare providers, and ensuring appropriate stewardship are imperative to achieve the desired objectives of the scheme in the long-run. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - October 6, 2023 Category: Health Management Source Type: research

VOLY: The Monetary Value of a Life-Year at the End of Patients ’ Lives
ConclusionsThe pressure to reimburse expensive therapies targeting EoL conditions will continue to increase. Delivering “value for money” in healthcare, both in countries with relatively higher and lower budget restrictions, requires the valuation of different types of health gains, which should, in turn, affect our ability to evaluate their cost effectiveness. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - October 4, 2023 Category: Health Management Source Type: research

Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions
ConclusionThis study expands the evidence base of psychometric performance of the PedsQL GCS and CHU9D and can aid in appropriate HRQOL instrument selection for the required context by researchers and clinicians. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - October 3, 2023 Category: Health Management Source Type: research

Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study
ConclusionParticipants experienced small utility gains from session attendance and weight loss during their programme participation. These benefits alone made this low-cost behaviour change programme potentially cost-effective in the short-term. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - October 3, 2023 Category: Health Management Source Type: research

Child –Parent Agreement in the Assessment of Health-Related Quality of Life Using the CHU9D and the PedsQLTM
ConclusionThis study highlights that the agreement between child and parent  proxy reported HRQoL may be influenced by both the measure used and the age of the child. These findings may have implications for the economic evaluation of healthcare interventions and services in child populations when both child and proxy perspectives are considered in the assessment of child HRQoL. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - September 29, 2023 Category: Health Management Source Type: research

Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - September 27, 2023 Category: Health Management Source Type: research

Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices
ConclusionNo evident price drops of included brand-name OMPs were observed around MEE and differences in purchase prices are modest in the selected Western European countries. Results were not subject to significance testing. More robust data are needed to strengthen negotiations with suppliers. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - September 26, 2023 Category: Health Management Source Type: research

Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review
ConclusionDespite favorable results towards the implementation of imaging biomarker-based CDx for cancer, there is room for improvement regarding the quantity and quality of economic evaluations, and that is expected as the  awareness of current study limitations increases and more clinical data become available in the future. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - September 25, 2023 Category: Health Management Source Type: research

The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022
ConclusionsThis study suggests PROs/PROMs are considered in less than half of total medicine assessments and even more rarely in some disease areas. The adoption of PROs is key in EMA strategy to 2025 and would be facilitated by consensus development on their measures and optimisation of data collection. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - September 2, 2023 Category: Health Management Source Type: research

Is Using Sodium-Glucose Cotransporter-2 Inhibitors to Treat Adults with Chronic Heart Failure Cost-Effective? A Systematic Review of Cost-Effectiveness Studies
ConclusionsUsing SGLT2i to treat heart failure is cost-effective, with more certainty in LVEF ≤ 40% compared to LVEF> 40%. Policymakers in jurisdictions where economic evaluations are not available could potentially use this study ’s findings to make informed decisions about treatment adoption.Systematic Review Protocol RegistrationThis study protocol  was registered with the International Prospective Register of Systematic Reviews (PROSPERO; CRD42023388701). (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - August 30, 2023 Category: Health Management Source Type: research

Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia
ConclusionPopulation targeting using mutation testing forTP53 andIGHV when performed with del(17p) testing specifically in the context of frontline ibrutinib choice does not make a cost-ineffective treatment into a cost-effective treatment. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - August 22, 2023 Category: Health Management Source Type: research

Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018 –2040
ConclusionThe novel information presented could help national policymakers anticipate possible areas for cost savings. Action should be taken on disease prevention, on reducing mortality and on delaying the age of death due to Hodgkin lymphoma, brain cancer, leukaemia and melanoma. Furthermore, the study findings enhance our understanding of macroeconomic variables and could be useful in determining a re-allocation of health expenditures. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - August 8, 2023 Category: Health Management Source Type: research

The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates
ConclusionThe results indicate both the direct and indirect impact of NCDs, but the indirect burden of loss of employment and productivity, despite its relevance, has been less studied in the literature. A robust economic analysis will allow an evidence-based policy decision perspective to reduce the rising burden of NCDs. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - July 28, 2023 Category: Health Management Source Type: research

Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - July 20, 2023 Category: Health Management Source Type: research